110402-20-5 Usage
General Description
3-Pyridinethiol, 2-amino-(9CI) is a chemical compound with the molecular formula C5H6N2S. It is also known as 2-Aminopyridine-3-thiol and has a molecular weight of 126.18 g/mol. 3-Pyridinethiol,2-amino-(9CI) is a derivative of pyridine and contains both an amino and a thiol group. It is commonly used in organic synthesis and pharmaceuticals as a building block for various chemical reactions. 3-Pyridinethiol, 2-amino-(9CI) is also known to have biological activity, particularly related to its role as a ligand for metal ions, making it potentially useful in the field of metalloenzyme research and drug development. However, it is important to handle this compound with care, as it can be hazardous if not properly handled and stored.
Check Digit Verification of cas no
The CAS Registry Mumber 110402-20-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,4,0 and 2 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 110402-20:
(8*1)+(7*1)+(6*0)+(5*4)+(4*0)+(3*2)+(2*2)+(1*0)=45
45 % 10 = 5
So 110402-20-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H6N2S/c6-5-4(8)2-1-3-7-5/h1-3,8H,(H2,6,7)
110402-20-5Relevant articles and documents
PROTEIN TYROSINE PHOSPHATASE INHIBITORS
-
Paragraph 00224; 00274, (2020/05/21)
Compounds of Formula la or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of hyperproliferative diseases in the view of their ability to inhibit SHP2. Methods of using compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
CARBACEPHEM β-LACTAM ANTIBIOTICS
-
Page/Page column 81, (2010/04/06)
Carbacephem -lactam antibiotics having structure (I) are disclosed, including stereoisomers, pharmaceutically acceptable salts, esters and prodrugs thereof, wherein Ar1, Ar2, R1 and R2 are as defined herein. The compounds are useful for the treatment of bacterial infections, in particular those caused by methicillin-resistant Staphylococcus spp.
